// App-Quantinova.ai

: Effective Chimeric Antigen Receptor T Cell Therapy for Relapsed and Refractory Acute Lymphoblastic Leukemia in Children Can be Administered Safely Under the Real-Time Monitoring of Th1/Th2 Cytokine Patterns Measured By the Cytometric Bead Array Technology

Researchers

Presenter

  • Yongmin Tang

Principal Investigators

  • Diying Shen

  • Lei Xiao

  • Hua Song

  • Fenying Zhao

  • Xiaojun Xu

  • Weiqun Xu

  • Di Wang

  • Juan Liang

  • Meixin Fang

  • Chan Liao

  • Sisi Li

  • Ning Zhao

  • Wei Huang

Medical Centers

  • Division of Neonatology, The Childrens Hospital of Zhejiang University School of Medicine, Hangzhou, China

  • Zhejiang University School of Medicine,, Hangzhou, China

  • Division of Neonatology, The Childrens Hospital of Zhejiang University School of Medicine, Hangzhou, China

  • Department of Hematology/Oncology, The Children's Hospital, Zhejiang University School of Medicine, Hangzhou, China

  • Department of Hematology/Oncology, The Children's Hospital, Zhejiang University School of Medicine, Hangzhou, China

Locations

  • China

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Acute lymphoblastic leukemia

  • B-cell acute lymphoblastic leukemia

Biomarkers

  • Cytokine

  • Interferon-gamma

  • Interleukin 10

  • Interleukin 4

  • Interleukin 6

  • Tumor necrosis factor

  • Cerebrospinal fluid

  • T helper 2

  • Type 1 T helper

Drug/Treatment

  • Interferon Gamma

  • Interleukin

  • Interferon

  • IFN-lambda

  • Interleukin-10

  • IL-4

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved